Cargando…
Evaluation and consequences of heterogeneity in the circulating tumor cell compartment
A growing understanding of the molecular biology of cancer and the identification of specific aberrations driving cancer evolution have led to the development of various targeted agents. Therapeutic decisions concerning these drugs are often guided by single biopsies of the primary tumor. Yet, it is...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5217044/ https://www.ncbi.nlm.nih.gov/pubmed/26980749 http://dx.doi.org/10.18632/oncotarget.8015 |